Hemoglobin News and Research

RSS

Vitamin B6 decreases risk of colorectal cancer

According to a study published in the American Gastroenterological Association (AGA) journal Gastroenterology, women with a high dietary intake of vitamin B6 over several years have a decreased risk of colorectal cancer (CRC).

5 Jun 2005

Sickle cell protects against malari

In this month's issue of the open access journal PLoS Medicine, Dr. Thomas N. Williams and colleagues from Kilifi, Kenya, show that the protection against malaria given by carrying the gene for sickle cell haemoglobin may involve the immune system.

30 May 2005

Viramidine demonstrates anti-HCV Genotype 1 activity that compares favorably to Ribavirin

Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).

23 Apr 2005

Researchers have identified a new clinical syndrome

Researchers have identified a new clinical syndrome that produces serious and sometimes fatal symptoms in a variety of seemingly unrelated diseases. The syndrome, described in the April 6 issue of the Journal of the American Medical Association, is caused by hemolysis, the destruction of red blood cells.

5 Apr 2005

Method of gene therapy accurately corrects mutations in disease-causing genes

Harnessing the strength of a natural process that repairs damage to the human genome, a researcher from UT Southwestern Medical Center has helped establish a method of gene therapy that can accurately and permanently correct mutations in disease-causing genes.

5 Apr 2005

Method of gene therapy that can accurately and permanently correct mutations in disease-causing genes

4 Apr 2005

Wolbachia genome reveals new targets to combat infectious disease

More than a billion people are at risk for infection with filarial nematodes, parasites that cause elephantiasis, African river blindness, and other debilitating diseases in more than 150 million people worldwide.

29 Mar 2005

Molecule that causes secondary stroke

Scientists at the University of Cincinnati (UC) College of Medicine have discovered the cause of a deadly type of secondary stroke known as cerebral vasospasm.

28 Mar 2005

Images of brain activity may hold clues to the onset of schizophrenia

Images of brain activity may hold clues to the onset of schizophrenia in people at high risk for the disease, according to a study headed by psychiatry researchers at the University of North Carolina at Chapel Hill School of Medicine.

21 Mar 2005

$3.2 million for two shock-related studies

A Virginia Commonwealth University research group has been awarded $3.2 million in federal grants for two shock-related studies, one with battlefield implications and the other for emergency medicine.

21 Mar 2005

Mountain dwellers live longer

People who live in mountain areas live longer than those living in lowland areas, according to research from Greece, which has the lowest death rate from heart disease of any developed country.

15 Mar 2005

Process behind cellular export of iron may help to explain human hemochromatosis

The first direct evidence that a single protein is critical in the cellular export of iron may help to explain human hemochromatosis, researchers report in the March issue of Cell Metabolism.

15 Mar 2005

Commonly used anesthetic regimen appears to have no negative effects on the developing brain of the fetus

An anesthetic regimen commonly used during surgery on pregnant mothers appears to have no negative effects on the developing brain of the fetus, according to a new study on sheep conducted by Duke University Medical Center researchers.

9 Mar 2005

Common anesthetics appear safe for developing fetal brain

A group of Dartmouth researchers has learned that the brain's auditory cortex, the part that handles information from your ears, holds on to musical memories.

9 Mar 2005

Studies find Aspirin resistance in up to 27% of Aspirin users

While aspirin remains a crucial and cost-effective therapy for the prevention and management of cardiovascular diseases, research suggests that a significant percentage of the 25 million Americans on a chronic aspirin regimen are "aspirin resistant," or do not achieve sufficient antiplatelet effects from aspirin.

7 Mar 2005

Crystallized molecular machine reveals possible new paths for treating diseases

The crystallized form of a molecular machine that can cut and paste genetic material is revealing possible new paths for treating diseases such as some forms of cancer and opportunistic infections that plague HIV patients.

21 Feb 2005

New York blood inventory has dropped to crisis proportions

The blood inventory of New York Blood Center, the majority supplier of blood to New York and New Jersey hospitals, has dropped to crisis proportions.

13 Feb 2005

Artemisinin could selectively kill cancer cells while leaving normal cells unharmed

Researchers at the University of Washington have blended the past with the present in the fight against cancer, synthesizing a promising new compound from an ancient Chinese remedy that uses cancer cells' rapacious appetite for iron to make them a target.

9 Feb 2005

New understanding of the causes for symptoms of sickle cell disease

A new understanding of the causes for symptoms of sickle cell disease, a condition affecting one in every 600 African-Americans, has resulted from a study by researchers at Duke University Medical Center and Howard Hughes Medical Institute (HHMI). Their findings may lead to a new, more direct method for treating the disease, they said.

31 Jan 2005

New malaria enzyme laid bare with help of computer calculations

Using only computers, a research team at Uppsala University in Sweden has managed to reveal both the structure and the function of a newly discovered enzyme from the most dangerous malaria parasite, Plasmodium falciparum.

8 Dec 2004